Background Postoperative cerebral infarction following coronary artery bypass grafting (CABG) for multivessel coronary artery ...
Background Though undiagnosed in many patients, especially those with cryptogenic stroke, atrial fibrillation (AF) is a key cause of ischaemic stroke. By allowing extended cardiac monitoring, ...
A NEW prospective study has revealed that patients with Takayasu arteritis (TA) who present with high ischaemic deficits on computed tomography perfusion (CTP) scans face a significantly increased ...
Discontinuing oral anticoagulation (OAC) therapy resulted in a lower risk of a composite of stroke, systemic embolism or major bleeding than continuing OAC therapy in patients who had successful ...
Perth-based biotech Argenica Therapeutics (ASX: AGN) has released top-line safety results from its Phase 2 trial evaluating lead candidate ARG-007 on patients with acute ischaemic stroke (AIS) who are ...
Fingolimod is an immunomodulatory drug that has shown promising effects in stroke treatment, including improvements in neurofunctional recovery and a reduction in infarct size. Fingolimod modulates ...
1 Chongqing Jiulongpo District Yuzhou Road Street Community Health Service Center, Chongqing, China 2 Department of Rheumatology and Immunology, Center for Immune Ageing and Rejuvenation, The First ...
Department of Neurology (J.B.L., E.O., D.H., B.M.G.), Duke University School of Medicine, Durham, NC. Department of Population Health Sciences (J.B.L., E.O.), Duke ...
Introduction: Dysphagia or disordered swallowing is a post-stroke condition that requires early intervention to improve stroke recovery. Individuals with dysphagia require specialized services to ...
A new study reveals that stroke may do more than damage the brain. Instead, strokes could rewire the gut microbiome, creating metabolic shifts that may lead to novel treatments and precision medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback